<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J Clin Invest</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26752645</article-id>
<article-id pub-id-type="pmc">4731159</article-id>
<article-id pub-id-type="publisher-id">81937</article-id>
<article-id pub-id-type="doi">10.1172/JCI81937</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcription factor ICBP90 regulates the <italic>MIF</italic> promoter and immune susceptibility locus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yao</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leng</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sauler</surname>
<given-names>Maor</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Weiling</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Junsong</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yi</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Xiaoqing</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Patty</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bucala</surname>
<given-names>Richard</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Departments of Medicine and Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.</aff>
<aff id="A2"><label>2</label>Department of Laboratory Medicine, Southwest Hospital, Third Military Medical University, Chongqing, China.</aff>
<aff id="A3"><label>3</label>Yale School of Public Health, New Haven, Connecticut, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Richard Bucala, Yale University School of Medicine, TAC S521, PO Box 208031, 300 Cedar Street, New Haven, Connecticut 06520-8031, USA. Phone: 203.785.2453; E-mail: <email>Richard.Bucala@Yale.edu</email>.</corresp>
</author-notes>
<pub-date date-type="pub" iso-8601-date="2016-01-11" publication-format="electronic">
<day>11</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date date-type="pub" iso-8601-date="2016-02-01" publication-format="print">
<day>1</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>5</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 3 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>126</volume>
<issue>2</issue>
<fpage>732</fpage>
<lpage>744</lpage>
<history>
<date date-type="received">
<day>23</day>
<month>3</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>11</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>American Society for Clinical Investigation</copyright-holder>
</permissions>
<self-uri xlink:href="https://www.jci.org/articles/view/81937">This article is available online at https://www.jci.org/articles/view/81937</self-uri>
<abstract>
<p>The immunoregulatory cytokine macrophage migration inhibitory factor (MIF) is encoded in a functionally polymorphic locus that is linked to the susceptibility of autoimmune and infectious diseases. The <italic>MIF</italic> promoter contains a 4-nucleotide microsatellite polymorphism (–794 CATT) that repeats 5 to 8 times in the locus, with greater numbers of repeats associated with higher mRNA levels. Because there is no information about the transcriptional regulation of these common alleles, we used oligonucleotide affinity chromatography and liquid chromatography–mass spectrometry to identify nuclear proteins that interact with the –794 CATT<sub>5–8</sub> site. An analysis of monocyte nuclear lysates revealed that the transcription factor ICBP90 (also known as UHRF1) is the major protein interacting with the <italic>MIF</italic> microsatellite. We found that ICBP90 is essential for <italic>MIF</italic> transcription from monocytes/macrophages, B and T lymphocytes, and synovial fibroblasts, and TLR-induced <italic>MIF</italic> transcription is regulated in an ICBP90- and –794 CATT<sub>5–8</sub> length–dependent manner. Whole-genome transcription analysis of ICBP90 shRNA–treated rheumatoid synoviocytes uncovered a subset of proinflammatory and immune response genes that overlapped with those regulated by MIF shRNA. In addition, the expression levels of ICBP90 and MIF were correlated in joint synovia from patients with rheumatoid arthritis. These findings identify ICBP90 as a key regulator of <italic>MIF</italic> transcription and provide functional insight into the regulation of the polymorphic <italic>MIF</italic> locus.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>